Objective assessment of motor slowness in Huntington's disease: Clinical correlates and 2-year follow-up

Movement Disorders

Volumn 19, Issue 3, 2004, Pages 285-297

  van Vugt, Jeroen P P ^a   Piet, Karlijne K E ^a   Vink, Liesbeth J ^a   Siesling, Sabine ^a   Zwinderman, Aeilko H ^a   Middelkoop, Huub A M ^a   Roos, Raymund A C ^a  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Akinesia; Bradykinesia; Follow up; Huntington's disease; Reaction time

Indexed keywords

ATYPICAL ANTIPSYCHOTIC AGENT; BENZODIAZEPINE; CHLORAL HYDRATE; MONOAMINE OXIDASE INHIBITOR; NEUROLEPTIC AGENT; SEROTONIN UPTAKE INHIBITOR; TETRABENAZINE; TRICYCLIC ANTIDEPRESSANT AGENT;

ADULT; AGED; AKINESIA; BODY MOVEMENT; BRADYKINESIA; CHOREA; COGNITIVE DEFECT; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FOLLOW UP; HUMAN; HUNTINGTON CHOREA; MAJOR CLINICAL STUDY; MALE; MEDICAL ASSESSMENT; MINI MENTAL STATE EXAMINATION; MOTOR DYSFUNCTION; MOTOR PERFORMANCE; NEUROLOGIC EXAMINATION; PHYSICAL CAPACITY; PHYSICAL DISABILITY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RATING SCALE; REACTION TIME; REVIEW; VOLUNTARY MOVEMENT; ARTICLE; HOSPITALIZATION; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; REPRODUCIBILITY; VALIDATION STUDY;

ADULT; AGED; COGNITION DISORDERS; FEMALE; FOLLOW-UP STUDIES; HUMANS; HUNTINGTON DISEASE; MALE; MIDDLE AGED; REACTION TIME; REPRODUCIBILITY OF RESULTS; SEVERITY OF ILLNESS INDEX;

EID: 3042578344     PISSN: 08853185     EISSN: None     Source Type: Journal    
DOI: 10.1002/mds.10718     Document Type: Review

References (88)

1. Thompson PD, Berardelli A, Rothwell JC, et al. The coexistence of bradykinesia and chorea in Huntington's disease and its implications for theories of basal ganglia control of movement. Brain 1988;111:223-244.
2. Folstein SE, Jensen B, Leigh RJ, Folstein MF. The measurement of abnormal movement: methods developed for Huntington's disease. Neurobehav Toxicol Teratol 1983;5:605-609.
3. Brandt J, Strauss ME, Larus J, Jensen B, Folstein SE, Folstein MF. Clinical correlates of dementia and disability in Huntington's disease. J Clin Neuropsychol 1984;6:401-412.
4. Young AB, Penney JB, Starosta Rubinstein S, et al. PET scan investigations of Huntington's disease: cerebral metabolic correlates of neurological features and functional decline. Ann Neurol 1986;20:296-303.
5. Hefter H, Hömberg V, Lange HW, Freund HJ. Impairment of rapid movement in Huntington's disease. Brain 1987;110:585-612.
6. Girotti F, Marano R, Soliveri P, Geminiani G, Scigliano G. Relationship between motor and cognitive disorders in Huntington's disease. J Neurol 1988;235:454-457.
7. Bradshaw JL, Phillips JG, Dennis C, et al. Initiation and execution of movement sequences in those suffering from and at-risk of developing Huntington's disease. J Clin Exp Neuropsychol 1992; 14:179-192.
8. Rothlind JC, Bylsma FW, Peyser C, Folstein SE, Brandt J. Cognitive and motor correlates of everyday functioning in early Huntington's disease. J Nerv Ment Dis 1993;181:194-199.
9. Bylsma FW, Rothlind J, Hall MR, Folstein SE, Brandt J. Assessment of adaptive functioning in Huntington's disease. Mov Disord 1993;8:183-190.
10. Sprengelmeyer R, Canavan AG, Lange HW, Hömberg V. Associative learning in degenerative neostriatal disorders: contrasts in explicit and implicit remembering between Parkinson's and Huntington's diseases. Mov Disord 1995;10:51-65.
11. Van Vugt JPP, Van Hilten JJ, Roos RAC. Hypokinesia in Huntington's disease. Mov Disord 1996;11:384-388.
12. Hausdorff JM, Cudkowicz ME, Firtion R, Wei JY, Goldberger AL. Gait variability and basal ganglia disorders: stride-to-stride variations of gait cycle timing in Parkinson's disease and Huntington's disease. Mov Disord 1998;13:428-437.
13. Sanchez-Pernaute R, Krung G, del Barrio A, de Yebenes JG, Vontobel P, Leenders KL. Bradykinesia in early Huntington's disease. Neurology 2000;54:119-125.
14. Garcia Ruiz PJ, Gomez Tortosa E, Sanchez Bernados V, Rojo A, Fontán A, Garcia de Yebenes J. Bradykinesia in Huntington's disease. Clin Neuropharmacol 2000;23:50-52.
15. Gordon AM, Quinn L, Reilmann R, Marder K. Coordination of prehensile forces during precision grip in Huntington's disease. Exp Neurol 2000;163:136-148.
16. Van Vugt JPP, Siesling S, Piet KKE, et al. Quantitative assessment of daytime motor activity provides a responsive measure of functional decline in patients with Huntington's disease. Mov Disord 2001;16:481-488.
17. Baroff GS, Falek A, Haberlandt W. Impairment of psychomotor function in the early diagnosis of Huntington's chorea. Wien Z Nervenheilkunde 1958;15:28-37.
18. Garnett ES, Firnau G, Nahmias C, Carbone R, Bartolucci G. Reduced striatal glucose consumption and prolonged reaction time are early features in Huntington's disease. J Neurol Sci 1984;65: 231-237.
19. David AS, Jeste DV, Folstein MF, Folstein SE. Voluntary movement dysfunction in Huntington's disease and tardive dyskinesia. Acta Neurol Scand 1987;75:130-139.
20. Jahanshahi M, Brown RG, Marsden CD. A comparative study of simple and choice reaction time in Parkinson's, Huntington's and cerebellar disease. J Neurol Neurosurg Psychiatry 1993;56:1169-1177.
21. Curra A, Agostino R, Galizia P, Fittipaldi F, Manfredi M, Berardelli A. Sub-movement cueing and motor sequence execution in patients with Huntington's disease. Clin Neurophysiol 2000;111: 1184-1190.
22. Churchyard AJ, Morris ME, Georgiou N, Chiu E, Cooper R, Iansek R. Gait dysfunction in Huntington's disease: parkinsonism and a disorder of timing. Implications for movement rehabilitation. Adv Neurol 2001;87:375-385.
23. Phillips JG, Bradshaw JL, Chiu E, Bradshaw JA. Characteristics of handwriting of patients with Huntington's disease. Mov Disord 1994;9:521-530.
24. Phillips JG, Bradshaw JL, Chiu E, Teasdale N, Iansek R, Bradshaw JA. Bradykinesia and movement precision in Huntington's disease. Neuropsychologia 1996;34:1241-1245.
25. Georgiou N, Phillips JG, Bradshaw JL, Cunnington R, Chiu E. Impairments of movement kinematics in patients with Huntington's disease: a comparison with and without a concurrent task. Mov Disord 1997;12:386-396.
26. Quinn L, Reilmann R, Marder K, Gordon AM. Altered movement trajectories and force control during object transport in Huntington's disease. Mov Disord 2001;16:469-480.
27. Serrien DJ, Burgunder JM, Wiesendanger M. Grip force scaling and sequencing of events during a manipulative task in Huntington's disease. Neuropsychologia 2001;39:734-741.
28. Quinn L, Hamel V, Flanagan JR, Kaminski T, Rubin A. Control of multijoint arm movements in Huntington's disease. J Neuro Rehab 1997;11:47-60.
29. Smith MA, Brandt J, Shadmehr R. Motor disorder in Huntington's disease begins as a dysfunction in error feedback control. Nature 2000;403:544-549.
30. Schwarz M, Fellows SJ, Schaffrath C, Noth J. Deficits in sensorimotor control during precise hand movements in Huntington's disease. Clin Neurophysiol 2001;112:95-106.
31. Siemers E, Foroud T, Bill DJ, et al. Motor changes in presymptomatic Huntington disease gene carriers. Arch Neurol 1996;53: 487-492.
32. Young AB, Shoulson I, Penney JB, et al. Huntington's disease in Venezuela: neurologic features and functional decline. Neurology 1986;36:244-249.
33. Penney JB, Young AB, Shoulson I, et al. Huntington's disease in Venezuela: 7 years of follow-up on symptomatic and asymptomatic individuals. Mov Disord 1990;5:93-99.
34. De Boo GM, Tibben A, Lanser JBK, et al. Early cognitive and motor symptoms in identified carriers of the gene for Huntington disease. Arch Neurol 1997;54:1353-1357.
35. Lawrence AD, Hodges JR, Rosser AE, et al. Evidence for specific cognitive deficits in prectinical Huntington's disease. Brain 1998; 121:1329-1341.
36. Kirkwood SC, Siemers E, Bond C, Conneally PM, Christian JC, Foroud T. Confirmation of subtle motor changes among presymptomatic carriers of the Huntington disease gene. Arch Neurol 2000;57:1040-1044.
37. The Huntington Study Group. Unified Huntington's Disease Rating Scale: reliability and consistency. Mov Disord 1996;11:136-142.
38. Siesling S, Van Vugt JPP, Zwinderman AH, Kieburtz K, Roos RAC. Unified Huntington's Disease Rating Scale: a follow-up. Mov Disord 1998;13:915-919.
39. Marder K, Zhao H, Myers RH, et al. Rate of functional decline in Huntington's disease. Neurology 2000;54:452-458.
40. Bachoud-Lévi AC, Maison P, Bartolomeo P, et al. Retest effects and cognitive decline in longitudinal follow-up of patients with early HD. Neurology 2001;56:1052-1058.
41. Reilmann R, Kirsten F, Quinn L, Henningsen H, Marder K, Gordon AM. Objective assessment of progression in Huntington's disease: a 3-year follow-up study. Neurology 2001;57:920-924.
42. Shoulson I, Fahn S. Huntington disease: clinical care and evaluation. Neurology 1979;29:1-3.
43. Folstein MF, Folstein SE, McHugh PR. "Mini-Mental State". A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 1975;12:189-198.
44. Shoulson I. Huntington disease: functional capacities in patients treated with neuroleptic and antidepressant drugs. Neurology 1981; 31:1333-1335.
45. Denny-Brown D. Diseases of the basal ganglia. Their relation to disorders of movement. I. Lancet 1960;2:1099-1105.
46. Penney JB, Young AB. Striatal inhomogeneities and basal ganglia function. Mov Disord 1986;1:3-15.
47. Albin RL, Young AB, Penney JB. The functional anatomy of basal ganglia disorders. Trends Neurosci 1989;12:366-375.
48. DeLong MR. Primate models of movement disorders of basal ganglia origin. Trends Neurosci 1990;13:281-285.
49. Berardelli A, Noth J, Thompson PD, et al. Pathophysiology of chorea and bradykinesia in Huntington's disease. Mov Disord 1999;14:398-403.
50. Van Vugt JPP, Siesling S, Vink L, Roos RAC. Clinical correlates of reaction time in Huntington's disease [abstract]. Mov Disord 1998;13:158.
51. Roman MJ, Delis DC, Filoteo JV, et al. Is there a "subcortical" profile of attentional dysfunction? A comparison of patients with Huntington's and Parkinson's diseases on a global-local focused attention task. J Clin Exp Neuropsychol 1999;20:873-884.
52. Snowden J, Craufurd D, Griffiths H, Thompson J, Neary D. Longitudinal evaluation of cognitive disorder in Huntington's disease. J Int Neuropsychol Soc 2001;7:33-44.
53. Georgiou N, Bradshaw JL, Phillips JG, Chiu E, Bradshaw JA. Reliance on advance information and movement sequencing in Huntington's disease. Mov Disord 1995;10:472-481.
54. Joel D. Open interconnected model of basal ganglia-thalamocortical circuitry and its relevance to the clinical syndrome of Huntington's disease. Mov Disord 2001;16:407-423.
55. Wexler NS. Perceptual-motor, cognitive, and emotional characteristics of persons at risk for Huntington's disease. Adv Neurol 1979;23:257-271.
56. Brown RG, Marsden CD. 'Subcortical dementia': the neuropsychological evidence. Neuroscience 1988;25:363-387.
57. Lundervold AJ, Karken NR, Reinvang I. Assessment of 'subcortical dementia' in patients with Huntington's disease, Parkinson's disease, multiple sclerosis and AIDS by a neuropsychological screening battery. Scand J Psychol 1994;35:48-55.
58. Baro F. A neuropsychological approach to early detection of Huntington's chorea. Adv Neurol 1973;1:329-338.
59. Georgiou N, Bradshaw JL, Phillips JG, Chiu E. Effect of directed attention in Huntington's disease. J Clin Exp Neuropsychol 1997; 19:367-377.
60. Roos RAC. Neuropathology of Huntington's chorea. In: Vinken PJ, Bruyn GW, Klawans HL, editors. Extrapyramidal disorders. Amsterdam: Elsevier; 1986. p 315-326.
61. Reiner A, Albin RL, Anderson KD, D'Amato CJ, Penney JB, Young AB. Differential loss of striatal projection neurons in Huntington disease. Proc Natl Acad Sci U S A 1988;85:5733-5737.
62. Storey E, Beal MF. Neurochemical substrates of rigidity and chorea in Huntington's disease. Brain 1993;116:1201-1222.
63. Van Vugt JPP, Stijl M, Roos RAC, Van Dijk JG. Impaired antagonist inhibition may contribute to akinesia and bradykinesia in Huntington's disease. Clin Neurophysiol 2003;114:295-305.
64. Roos RAC, Hermans J, Vegter van der Vlis M, van Ommen GJ, Bruyn GW. Duration of illness in Huntington's disease is not related to age at onset. J Neurol Neurosurg Psychiatry 1993;56: 98-100.
65. Mayeux R, Stern Y, Herman A, Greenbaum L, Fahn S. Correlates of early disability in Huntington's disease. Ann Neurol 1986;20: 727-731.
66. Feigin A, Kieburtz K, Bordwell K, et al. Functional decline in Huntington's disease. Mov Disord 1995;10:211-214.
67. Georgiou N, Bradshaw JL, Phillips JG, Bradshaw JA, Chiu E. The Simon effect and attention deficits in Gilles de la Tourette's syndrome and Huntington's disease. Brain 1995;118:1305-131S.
68. Sprengelmeyer R, Lange H, Hömberg V. The pattern of attentional deficits in Huntington's disease. Brain 1995;118:145-152.
69. Fedio P, Cox CS, Neophyrides A, Canal-Frederick G, Chase TN. Neuropsychological profile of Huntington's disease: patients and those at risk. Adv Neurol 1979;23:139-255.
70. Mohr E, Brouwers P, Claus JJ, Mann UM, Fedio P, Chase TN. Visuospatial cognition in Huntington's disease. Mov Disord 1991; 6:127-132.
71. Filoteo JV, Delis DC, Roman MJ, et al. Visual attention and perception in patients with Huntington's disease: comparisons with other subcortical and cortical dementias. J Clin Exp Neuropsychol 1995;17:654-667.
72. Lawrence AD, Watkins LH, Sahakian BJ, Hodges JR, Robbins TW. Visual object and vistrospatial cognition in Huntington's disease: implications for information processing in corticostriatal circuits. Brain 2000;123:1349-1364.
73. Cope MT, Georgiou N, Bradshaw JL, Iansek R, Phillips JG. Simon effect and attention in Parkinson's disease: a comparison with Huntington's disease and Tourette's syndrome. J Clin Exp Neuropsychol 1996;18:276-290.
74. Johnson KA, Cunnington R, Iansek R, Bradshaw JL, Georgiou N, Chiu E. Movement-related potentials in Huntington's disease: movement preparation and execution. Exp Brain Res 2001;138:492-499.
75. Brown RG, Jahanshahi M, Marsden CD. The execution of bimanual movements in patients with Parkinson's, Huntington's and cerebellar disease. J Neurol Neurosurg Psychiatry 1993;56:295-297.
76. Garcia Ruiz PJ, Mena MA, Sanchez Bernardos V, et al. Cerebrospinal fluid homovanillic acid is reduced in untreated Huntington's disease. Clin Neuropharmacol 1995;18:58-63.
77. Bonfiglioli C, DeBerti G, Nichelli P, Nicoletti R, Castiello U. Kinematic analysis of the reach to grasp movement in Parkinson's and Huntington's disease subjects. Neuropsychologia 1998;36:1203-1208.
78. Agostino R, Berardelli A, Formica A, Accomero N, Manfredi M. Sequential arm movements in patients with Parkinson's disease, Huntington's disease and dystonia. Brain 1992;115:1481-1495.
79. Phillips JG, Chiu E, Bradshaw JL, Iansek R. Impaired movement sequencing in patients with Huntington's disease: a kinematic analysis. Neuropsychologia 1995;33:365-369.
80. Priori A, Polidori L, Rona S, Manfredi M, Berardelli A. Spinal and cortical inhibition in Huntington's chorea. Mov Disord 2000;15: 938-946.
81. Huttunen J, Hömberg V. EMG responses in leg muscles to postural perturbations in Huntington's disease. J Neurol Neurosurg Psychiatry 1990;53:55-62.
82. Fellows S, Schwarz M, Schaffrath C, Domges F, Noth J. Disturbances of precision grip in Huntington's disease. Neurosci Lett 1997;226:103-106.
83. Petit H, Milbled G. Anomalies of conjugate ocular movements in Huntington's chorea: application to early detection. Adv Neurol 1973;1:287-294.
84. Oepen G, Mohr U, Willmes K, Thoden U. Huntington's disease: visuomotor disturbance in patients and offspring. J Neurol Neurosurg Psychiatry 1985;48:426-433.
85. Bollen E, Reulen JPH, Den Heyer JC, Van der Kamp W, Roos RAC, Buruma OJS. Horizontal and vertical saccadic eye movement abnormalities in Huntington's chorea. J Neurol Sci 1986;74:11-22.
86. Tsai TT, Lasker A, Zee DS. Visual attention in Huntington's disease: the effect of cueing on saccade latencies and manual reaction times. Neuropsychologia 1995;33:1617-1626.
87. Heindel WC, Butters N, Salmon DP. Impaired learning of a motor skill in patients with Huntington's disease. Behav Neurosci 1988; 102:141-147.
88. Gabrieli JD, Stebbins GT, Singh J, Willingham DB, Goetz CG. Intact mirror-tracing and impaired rotary-pursuit skill learning in patients with Huntington's disease: evidence for dissociable memory systems in skill learning. Neuropsychology 1997;11:272-281.